Those who applied for < GV(045890) > hit the upper limit in just one day! Achieved 30% profit!
Congratulations to everyone who applied for the free trial. ^^
A drug called ‘aprotinin’, which prevents excessive bleeding during surgery but is rarely used due to reported side effects, has shown potential as a treatment for COVID-19, according to research published on the 30th of last month (local time) in the international journal ‘Cell’.
"Buy and it falls, sell and it rises" ? this happened more than once. It was so tough that I thought about quitting stocks several times. Desperate, I applied for the 3-day free trial, and my stock life changed 180 degrees. I regret not applying sooner because my account profit rate was so good. I am still very satisfied and using the VIP service.
(VIP full-time investor Kim Yong-su, 47 years old)
Now think this is your last chance. If you miss this opportunity, you have to quit.
Exactly on “November 04” it will explode! Don’t miss out and regret it, buy at least 1 million KRW worth!
[AI recent upper limit hits]
*20.11.02 Syswork(269620) hit upper limit!
*20.10.30 Namseong(004270) hit upper limit!
*20.10.27 Phoenix Materials(050090) hit upper limit!
*20.10.23 ANP(015260) hit upper limit!
*20.10.21 Kyungin Electronics(009140) hit upper limit!
*20.10.19 KPX Life Science(114450) hit upper limit!
*20.10.16 Seohan(011370) hit upper limit!
*20.10.14 KMH Hightech(052900) hit upper limit!
*20.10.12 Access Bio(950130) hit upper limit!
*20.10.07 Camu E&C(013700) hit upper limit!
*20.10.05 Cellid(299660) hit upper limit!
▶▶ Only for exactly 30 people. “Wednesday upper limit”! ▶ Get it now ◀
※ First-come, first-served 30 people closed! Both early and late rounds are over. The hero of the last injury time winning goal ※
[Today's stocks of interest]
#SamsungElectronics #BaxelBio #ABProBio #OrientBio #Syswork
※ This content is unrelated to Asia Economy’s editorial direction, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

